IFI-U · Nucleotide Synergy

Specimen SS-F-UMA-286 // UMAMI · IFI-U

Nucleotide Synergy I-PR-B

Glycine max

Soybean

Tier INucleotide Synergy

Target Trait

2.3×

fold-change

IMP + GMP combined nucleotide synergy score

Technical Specifications

SKU

SS-F-UMA-286

Genomic Edits

6

GC Content

48.5-54.5%

Construct Length

3,573 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

mGluR1 / TAS1R1-TAS1R3

IFI Score

230

Pathway Edits

  • GmADSS adenylosuccinate synthase overexpression for elevated IMP via de-novo purine pathway in Glycine max seed tissue
  • GmIMPDH2 inosine monophosphate dehydrogenase balanced overexpression for IMP/GMP co-accumulation without net IMP depletion
  • GmGMPS GMP synthase activity tuned to 60% of IMPDH output to maintain 1.7:1 IMP:GMP ratio for maximum synergy
  • GmADSL adenylosuccinate lyase upregulation ensuring AMP/IMP cycling prevents adenylate deficiency during IMP accumulation phase
  • GmNT5C 5′-nucleotidase expression calibrated via synthetic promoter strength to maintain free nucleotide fraction over phosphorylated forms
  • GmPNP purine nucleoside phosphorylase isoform 2 overexpression for nucleoside salvage amplification across IMP and GMP branches

Key Interventions

Synergistic 5′-IMP + 5′-GMP co-accumulation at optimized 1.7:1 ratio for maximum mGluR1 and TAS1R1/TAS1R3 receptor co-activationTriple co-agonism via IMP + GMP + free glutamate co-engineering for IFI-U score multiplication beyond individual nucleotide effectsPurine pathway flux balancing preventing adenylate pool depletion while sustaining maximal IMP/GMP steady-state concentrations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
230
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Soy-based umami concentrates, plant-based meat flavor systems, and fermented tofu products where dual-nucleotide synergy delivers maximum umami without exogenous additives. Ideal for functional food ingredient manufacturers.

License

$349 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Umami · IFI-UAll Modalities